Veerhealth Care Limited - e-commerce in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN L65910MH1992PLC067632 Incorporated 10 July 1992 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Listed - BSE: 511523 Public Limited Company e-commerce
Market Cap
₹106 Cr
VEERHEALTH · BSE
Share Price
₹53.85
+1.74% today
Revenue
₹32.48 Cr
FY 2025-26 · +94.8% YoY
EBITDA
₹2.15 Cr
Margin 6.6%
Net Profit
₹0.68 Cr
FY 2025-26 · +74.4% YoY
P/E (TTM)
80.2x
P/B 4.6x
ROE
3.0%
ROCE 6.5%
Debt / Equity
0.21
Interest cover 46.5x

About Veerhealth Care Limited

Data last updated:

Veerhealth Care Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the online healthcare product retail segment of the e-commerce sector. It was incorporated on 10 July 1992 and has been in existence for over 34 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L65910MH1992PLC067632. Its GSTIN is 27AAACN1407B1Z6 (Maharashtra). The company holds 2 GST registrations, all of them active. It is a listed company as per MCA records. Its shares are listed on BSE: 511523.

The company has an authorised share capital of ₹45 Cr and a paid-up capital of ₹20 Cr. It was formerly known as Niyati Industries Limited. It is led by directors including Bhavin Satish Shah (Managing Director) and Nilesh Kantilal Shah.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Mumbai, Maharashtra.

As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹32.48 Cr, a growth of 94.8% compared to the previous year. For the same year it recorded a net profit of ₹68 Lakh (net margin 2.1%) and EBITDA of ₹2.15 Cr (EBITDA margin 6.6%). The net worth stands at ₹22.92 Cr (up 3.2% YoY). Total assets are valued at ₹30.16 Cr (up 0.4% YoY).

The company has about 5 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Veerhealth Care. As per MCA filings, the company has open charges of ₹7.5 Cr and satisfied charges of ₹7.37 Cr on record. Court records list 13 cases involving the company, including 5 filed by the company and 8 filed against it; 2 cases are pending. The company has 183 deals on record (183 market trades); the latest was in August 2026. Its 6 peer companies in the Healthcare industry (Ayurvedic Products and Services), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 4 smaller; the largest is Fabino Enterprises Limited with revenue of ₹18.33 Cr.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website veerhealthcare.net.

Company details

CIN L65910MH1992PLC067632
Registration Number 067632
Incorporation Date 10 July 1992
ROC Mumbai
Listing Status Listed - Listed on BSE (511523)
Company Status Active
Compliance Status Active Compliant

Contact details

Veerhealth Care Limited's registered office is in Mumbai, Maharashtra. Its website is veerhealthcare.net. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    629 – A 1st Floor Gazdar House Dhobi Talao Jagannath Shankarsheth Marg Kalbadevi P, Ost Office, Mumbai, Maharashtra, India – 400002
  • Industry
    E-Commerce, Online Healthcare Product Retail

To see the full contact details of Veerhealth Care Limited, buy the company report.

Comprehensive company report
Veerhealth Care Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Veerhealth Care operates one associated brand: Veerhealth Care. Each brand links to its own profile.

BrandDescriptionWebsite
Manufacturer of ayurveda medicinal productsveerhealthcare.net

Business activity

The main business activity of Veerhealth Care is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Veerhealth Care Limited, buy the company report.

Financials of Veerhealth Care Limited

FY 2025-26 filings available

Veerhealth Care Limited reported revenue of ₹32.48 Cr (up 94.8% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Standalone
Revenue
₹32.48 Cr
+94.8% YoY
EBITDA
₹2.15 Cr
+367.4% YoY
Profit After Tax
₹0.68 Cr
+74.4% YoY
Net Worth
₹22.92 Cr
+3.2% YoY
Total Assets
₹30.16 Cr
+0.4% YoY
Total Debt
₹4.58 Cr
-6.7% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue32.4816.6713.2213.279.6310.5811.73
Revenue growth+94.8%+26.1%-0.4%+37.8%-9.0%-9.8%-
EBITDA2.150.460.600.50(0.81)0.070.68
EBITDA margin+6.6%+2.8%+4.5%+3.8%-8.4%+0.7%+5.8%
Profit before tax1.260.511.271.120.250.580.65
Net profit0.680.390.391.58(0.06)0.380.32
Net profit margin+2.1%+2.3%+3.0%+11.9%-0.6%+3.6%+2.7%
EPS (₹)0.270.200.201.58(0.11)0.550.46
Balance sheet
Total assets30.1630.0524.6124.1316.8816.9616.46
Net worth22.9222.2221.8421.4313.9514.0413.75
Total debt4.584.910.000.000.001.732.48
Cash & bank0.461.160.243.610.400.100.02
Net working capital5.825.8110.699.373.765.575.14
Cash flow
Cash from operations4.194.512.90(0.70)1.811.00(0.36)
Cash from investing(4.43)(8.20)(0.28)(1.79)(1.09)(0.09)(1.67)
Cash from financing(0.46)4.61(5.99)5.69(0.42)(0.83)1.85
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue22.3524.9316.767.263.984.495.623.84
Revenue growth (YoY)+461.6%+455.2%+198.2%+89.1%-22.7%+118.0%--
Other income0.190.160.22(0.29)0.230.650.430.18
Total expenses20.5023.0216.346.023.454.525.783.68
EBITDA1.851.910.421.240.53(0.03)(0.16)0.16
EBITDA margin+8.3%+7.7%+2.5%+17.1%+13.3%-0.7%-2.8%+4.2%
Depreciation0.410.360.350.350.310.280.260.25
Interest0.200.230.110.100.100.100.140.01
Profit before tax1.431.480.180.500.350.24(0.13)0.08
Tax0.230.250.530.090.090.00(0.03)0.00

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 17 Nov 2026
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue22.3524.9316.767.263.984.495.623.84
Revenue growth (YoY)+461.6%+455.2%+198.2%+89.1%-22.7%+118.0%--
Other income0.190.160.22(0.29)0.230.650.430.18
Total expenses20.5023.0216.346.023.454.525.783.68
EBITDA1.851.910.421.240.53(0.03)(0.16)0.16
EBITDA margin+8.3%+7.7%+2.5%+17.1%+13.3%-0.7%-2.8%+4.2%
Depreciation0.410.360.350.350.310.280.260.25
Interest0.200.230.110.100.100.100.140.01
Profit before tax1.431.480.180.500.350.24(0.13)0.08
Tax0.230.250.530.090.090.00(0.03)0.00
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue32.4816.6713.2213.279.6310.5811.73
Revenue growth+94.8%+26.1%-0.4%+37.8%-9.0%-9.8%-
Other income0.801.221.391.241.671.200.48
Total expenses30.3316.2112.6212.7710.4410.5111.05
Employee cost0.001.581.310.900.880.830.80
EBITDA2.150.460.600.50(0.81)0.070.68
EBITDA margin+6.6%+2.8%+4.5%+3.8%-8.4%+0.7%+5.8%
Depreciation1.290.910.710.620.520.470.32
Interest0.400.260.010.000.090.220.19
Profit before tax1.260.511.271.120.250.580.65
Tax0.710.120.88(0.46)0.310.200.33
Net profit0.680.390.391.58(0.06)0.380.32
Net profit margin+2.1%+2.3%+3.0%+11.9%-0.6%+3.6%+2.7%
EPS (₹)0.270.200.201.58(0.11)0.550.46
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital20.0020.0020.0010.006.936.936.93
Reserves & surplus2.922.221.8411.437.027.116.82
Shareholders' funds (net worth)22.9222.2221.8421.4313.9514.0413.75
Secured loans4.584.910.000.000.001.732.48
Unsecured loans0.000.000.000.000.000.000.00
Total debt4.584.910.000.000.001.732.48
Total liabilities30.1630.0524.6124.1316.8816.9616.46
Assets
Gross block29.7024.8516.0315.0512.9611.3710.88
Net block23.4319.8711.9712.0110.549.489.45
Capital work in progress0.000.000.000.000.000.000.00
Investments0.000.000.000.000.000.000.00
Inventories4.452.441.402.612.121.661.23
Sundry debtors9.740.983.921.841.541.540.94
Cash & bank balances0.461.160.243.610.400.100.02
Loans & advances3.824.077.902.282.163.534.00
Total current assets18.478.6513.4610.346.226.836.19
Total current liabilities12.652.842.770.972.461.261.05
Net working capital5.825.8110.699.373.765.575.14
Total assets30.1630.0524.6124.1316.8816.9616.46
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash1.160.243.610.400.100.020.18
Net cash from operating activities4.194.512.90(0.70)1.811.00(0.36)
Net cash from investing activities(4.43)(8.20)(0.28)(1.79)(1.09)(0.09)(1.67)
Net cash from financing activities(0.46)4.61(5.99)5.69(0.42)(0.83)1.85
Net change in cash(0.70)0.92(3.37)3.210.300.09(0.17)
Closing cash0.461.160.243.610.400.100.02
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+94.8%+26.1%-0.4%+37.8%-9.0%-9.8%-
EBITDA growth+367.4%-23.3%+20.0%+161.7%-1257.1%-89.7%-
PBT growth+103.2%-51.2%+13.4%+348.0%-56.9%-10.8%+71.1%
Net income growth+74.4%0.0%-75.3%+2733.3%-115.8%+18.8%-
Revenue CAGR (3Y)+34.8%+20.6%+7.7%+4.2%+17.2%+27.0%+82.8%
EBITDA CAGR (3Y)+62.6%-+104.7%-9.7%---
Profitability & leverage
Net income margin+1.7%+2.3%+3.0%+11.9%-0.6%+3.6%+2.7%
Return on capital employed+6.5%+3.2%+5.3%+5.4%+2.0%+4.8%+5.4%
Return on net worth+3.0%+1.8%+1.9%+8.9%-0.5%+2.7%+2.4%
Debt / equity0.210.110.000.000.060.150.13
Long-term debt / equity0.180.100.000.000.050.120.08
Interest cover46.51-185.71-9.090.00-6.77-55.0052.78
Efficiency & per share
Fixed asset turnover1.190.830.850.950.790.951.34
Inventory turnover9.438.796.595.615.107.3211.33
Debtors turnover6.066.894.597.856.258.5313.96
EPS (₹)0.270.200.201.58(0.11)0.550.46
Dividend per share (₹)0.000.000.000.000.000.000.00
Book value per share (₹)11.4611.1110.9221.4320.1220.2519.84

To see the full year-wise statements and ratios of Veerhealth Care Limited, buy the company report.

Board of directors and KMP of Veerhealth Care Limited

Veerhealth Care Limited currently reports 6 directors and 1 key managerial person. 10 former directors have served the organization.

Current Directors and KMP
NameDesignationAppointment DateTenureStatus
Nilesh Kantilal ShahDirector14 Aug 20233 Years 3 MonthsCurrent
Yogesh Mahasukhlal ShahDirector15 Jun 201115 Years 5 MonthsCurrent
Chetan Hasmukhlal MehtaDirector14 Aug 20233 Years 3 MonthsCurrent
Akash Prakash ShahCfo10 Feb 20179 Years 9 MonthsCurrent
Prakashbhai Chandulal ShahDirector14 Aug 20233 Years 3 MonthsCurrent
Shruti Yogesh ShahDirector12 Sep 201412 Years 2 MonthsCurrent
Showing 6 of 7 current directors and KMP. View all directors and KMP

Peer comparison

Veerhealth Care Limited is compared with the 6 companies closest to it by revenue in the Healthcare industry (Ayurvedic Products and Services), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Veerhealth Care Limitedthis company₹32.48 Cr (FY 2026)₹68 Lakh2.1%94.8%5Mumbai, Maharashtra, India
Fabino Enterprises Limited₹18.33 Cr (FY 2025)-13.0%Sonipat, Haryana, India
Dhathri Life Sciences Private Limited₹18.11 Cr (FY 2024)9.0%Kayamkulam, Kerala, India
Girnar Ayurvedic Pharmacy Private Limited₹17.85 Cr (FY 2024)-8.0%Ahmedabad, Gujarat, India
Sakti Naturals Private Limited₹17.49 Cr (FY 2024)11.0%Villupuram, Tamil Nadu, India
Sana Herbals Pvt. Ltd.₹17.47 Cr (FY 2024)1.0%New Delhi, Delhi, India
Kniss Laboratories Private Limited₹17.41 Cr (FY 2023)-13.0%Chennai, Tamil Nadu, India

To see the full peer comparison of Veerhealth Care Limited, buy the company report.

Auditor

Veerhealth Care Limited is audited by Jayesh R. Shah & Co. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Jayesh R. Shah & Co.FY 2023104182W

Shareholding

Shareholding for the quarter ended Sep 2026: promoters hold 31.90%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 68.10%.

Promoters: 31.90%Retail & Others: 68.10%
Sep 2026
QUARTER
31.90% Promoters
68.10% Retail & Others
Promoter holding - history
Now 31.90% · Sep 2026High 31.90% · Sep 2026Low 31.50% · Dec 2025
30%30.8%31.5%32.3%33%Dec 2025Mar 2026Jun 2026Sep 2026Dec 2025: 31.50%Mar 2026: 31.50%Jun 2026: 31.50%Sep 2026: 31.90%31.50%31.90%
Shareholding trend - last 6 quarters
Sep 2026Jun 2026Mar 2026Dec 2025
Promoters31.90%31.50%31.50%31.50%
Public68.10%68.50%68.50%68.50%

Charges & borrowings

Open charges
₹7.5 Cr
Satisfied charges
₹7.37 Cr
Breakdown by lending institutions
Others₹7.50 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
27 Sep 2024100996616Others₹7.5 CrOpen
17 Dec 2020100394922Sidbi₹47.09 LakhSatisfied
27 Dec 2019100314216Hdfc Bank Limited₹2 CrSatisfied
23 Jul 2019100278482Sidbi₹2.9 CrSatisfied
31 Dec 201410539830Hdfc Bank Limited₹2 CrSatisfied

To see the full charge records of Veerhealth Care Limited, buy the company report.

Total charge records: 5 View all charges

Deals & funding

Veerhealth Care Limited has 183 deals on record (183 market trades); the latest was in August 2026.

Total deals
183
Market trades
183

Deals on record (5 of 183)

WhenDealAmountParties
Jun 2026Market trade₹25.4 LakhBuyer: an individual
Seller: Ishaan Tradefin LLP
Sep 2025Market trade₹18 LakhBuyer: Rishabh Fintrade Ltd
Seller: an individual
Sep 2025Market trade₹18.1 LakhBuyer: Rishabh Fintrade Ltd
Seller: an individual
Sep 2025Market trade₹18.6 LakhBuyer: Rishabh Fintrade Ltd
Seller: an individual
Feb 2024Market trade₹52.7 LakhBuyer: Shubham Financial Services
Seller: Dhwaja Shares & Securities Private Limited

To see the full deal history of Veerhealth Care Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Veerhealth Care Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Veerhealth Care Limited has a workforce of 5 employees on its EPFO records as of May 2026, across 2 active EPFO establishments.

Employee count
5
Active EPFO establishments
2

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-275
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Veerhealth Care Limited, buy the company report.

GST

Veerhealth Care has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
27AAACN1407B1Z6MaharashtraActive01 Jul 2017
24AAACN1407B1ZCGujaratActive01 Jul 2017

To see the full GST registrations and return filing status of Veerhealth Care Limited, buy the company report.

Recent activity

Veerhealth Care Limited has 17 board changes on record since 2009: 7 appointments and 10 cessations. The latest: Arvind Maganlal Shah ceased to be Director on 31 Mar 2024.

Filing
Veerhealth Care Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Mumbai I.
AGM
Veerhealth Care Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge registered on 27 Dec 2019 via Charge ID 100314216 with Hdfc Bank Limited was fully satisfied on 18 Oct 2024.
Charges
A charge with Others of Rs. 7.50 Cr registered on 27 Sep 2024 with Charge ID 100996616 was modified on 14 Oct 2024.
Charges
A charge with Others amounted to Rs. 7.50 Cr with Charge ID 100996616 was registered on 27 Sep 2024.
Ceased
Arvind Maganlal Shah ceased to be Director.
Ceased
Mitesh Jyotish Kuvadia ceased to be Director.
Appointed
Chetan Hasmukhlal Mehta was appointed as Director.
Appointed
Nilesh Kantilal Shah was appointed as Director.
Appointed
Prakashbhai Chandulal Shah was appointed as Director.
Charges
A charge registered on 23 Jul 2019 via Charge ID 100278482 with Sidbi was fully satisfied on 29 Jul 2021.
Charges
A charge registered on 17 Dec 2020 via Charge ID 100394922 with Sidbi was fully satisfied on 06 May 2021.

19 earlier events are in the company report.

Frequently asked questions

Veerhealth Care is an active public limited company based in Mumbai, Maharashtra, India. The company works in online healthcare product retail, within the e-commerce industry. It was incorporated on 10 July 1992 (34+ years old) and is registered under CIN L65910MH1992PLC067632. Listed on BSE: 511523.

Veerhealth Care reported revenue of ₹32.48 Cr for FY 2025-26 (up 94.8% YoY) based on standalone financials.

Veerhealth Care has 7 current directors and KMP:

The latest financial statements of Veerhealth Care on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Veerhealth Care is 27AAACN1407B1Z6, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AAACN1407B1ZC (Gujarat).

The CIN (Corporate Identification Number) of Veerhealth Care is L65910MH1992PLC067632. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Veerhealth Care is a listed company as per MCA records. Its shares are listed on BSE (code: 511523).

Veerhealth Care has 13 court cases on record: 5 filed by the company and 8 filed against it. 2 are pending. Most are in the district courts.

Veerhealth Care was incorporated on 10 July 1992, making it 34+ years old. It is registered with the Registrar of Companies, Mumbai.

Veerhealth Care has 183 deals on record (183 market trades); the latest was in August 2026.

The peers of Veerhealth Care by revenue are Fabino Enterprises Limited, Dhathri Life Sciences Private Limited, Girnar Ayurvedic Pharmacy Private Limited, Sakti Naturals Private Limited, Sana Herbals Pvt. Ltd. and 1 more, all in the Healthcare industry (Ayurvedic Products and Services), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).